Christopher Dinsmore - May 16, 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Chief Scientific Officer
Signature
/s/ Christopher Murphy, Attorney-in-Fact
Stock symbol
THRD
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/20/2024, 04:35 PM
Previous filing
Jan 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Employee Stock Option (right to buy) Award $0 +210K $0.00 210K May 16, 2024 Common Stock 210K $14.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares vest on May 16, 2025, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.